Market Research Report

Global Immuno-Oncology Assay Market Research Report: Forecast (2023-2028)

By Product & Services (Reagents and Antibodies, Testing Kits, Instruments, Consumables & Accessories, Software), By Assay Type (Checkpoint Inhibitor Assays, Cytokine Profiling Assa...ys, Protein Biomarker Assays, Genomic Sequencing and Mutational Analysis, Immune Profiling Assays, Tumour Biomarker Assays, Others (Gene Expression Profiling Assays, Multiplex Assays, etc.)), By Technology (Polymerase Chain Reaction, Immunoassay, Next-generation Sequencing, In-situ Hybridization, Flow Cytometry, Others (Mass Spectrometry, Immunohistochemistry (IHC), etc.)), By Indication, (Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Ovarian Cancer, Others (Bladder Cancer, Melanoma, etc.)), By Application (Clinical Assay, Research & Development), By End User (Hospitals, Cancer Research Centers, Specialty Cancer Clinics, Clinical Laboratories, Others (Contract Research Organizations (CROs), Contract Development & Manufacturing Organizations (CDMOs), etc.)), By Region (North America, South America, Europe, Middle East & Africa, Asia-Pacific), By Company (Agilent Technologies Inc., Aviva Systems Biology Corporation, PerkinElmer Inc., Bio-Rad Laboratories, Inc., Illumina Inc., Qiagen N.V, Thermo Fisher Scientific, Inc., Sartorius AG, NanoString Technologies, Inc., BioGenex, Abbott Laboratories, Inc., Asuragen Inc., Meso Scale Assay, LLC, Merck Millipore, Enzo Biochem Inc., and Others) Read more

  • Healthcare
  • Sep 2023
  • 188
  • PDF, Excel, PPT

Market Definition

The Global Immuno-Oncology Assay Market involves the development and distribution of diagnostic tools for detecting and characterizing cancers within the field of Immuno-Oncology. The market focuses on biomarker assays, genetic profiling, and immune system assessments to enable early cancer diagnosis, prognosis, and personalized treatment selection.

Market Insights & Analysis: Global Immuno-Oncology Assay Market (2023-28):

The Global Immuno-Oncology Assay Market size is valued at around USD 5.77 billion in 2024 and is estimated to grow at a CAGR of around 12.5% during the forecast period, i.e., 2023-28. The market growth has been supported by several factors reshaping the cancer diagnosis and treatment landscape. One of the primary factors has been the escalating global cancer incidence, which led to the critical need for more precise diagnostic tools and effective therapeutic strategies.

Furthermore, Immuno-Oncology is an innovative field harnessing the body’s immune system to combat cancer and has been experiencing significant popularity among healthcare professionals. It has led to a new era of personalized medicine, which has led to a heightened focus on Assays capable of targeting unique biomarkers and immunological sites. These assays held the potential to guide treatment decisions, predict therapy responses, and ultimately improve patient outcomes. Hence, their adoption has improved among the healthcare professionals offering cancer treatment.

Report Coverage Details
Study Period Historical Data: 2018-21
Base Year: 2022
Forecast Period: 2023-28
CAGR (2023-2028) 12.5%
Regions Covered North America: US, Canada, Mexico
Europe: The UK, Germany, Italy, France, Spain, Rest of Europe,
Asia-Pacific: China, India, Japan, South Korea, Australia, Rest of Asia-Pacific
South America: Brazil, Rest of South America
Middle East & Africa: GCC, South Africa, Rest of MEA
Key Companies Profiled Agilent Technologies Inc., Aviva Systems Biology Corporation, PerkinElmer Inc., Bio-Rad Laboratories, Inc., Illumina Inc., Qiagen N.V, Thermo Fisher Scientific, Inc., Sartorius AG, NanoString Technologies, Inc., BioGenex, Abbott Laboratories, Inc., Asuragen Inc., Meso Scale Assay, LLC, Merck Millipore, Enzo Biochem Inc., and Others
Market Value (2024) USD 5.77 billion

 

Moreover, pharmaceutical companies like Novartis, Merck, etc. are pioneering novel Immuno-Oncology Assay, including liquid biopsies and immune profiling assays. These technologies enable early cancer detection, predict treatment responses, and enhance patient outcomes. Thus, with increased R&D investments and regulatory approvals, they are supporting the growth of the Global Immuno-Oncology Assay Market, through creating a shift towards personalized cancer care and more effective therapies. These investments are aimed at improving cancer detection and therapy outcomes. Also, through their efforts in ongoing research and clinical trials, they are advancing the development of an innovative Immuno-Oncology Assay. Consequently, it would further improve the inclination of healthcare professionals in cancer care, which would support the market growth in the coming years as well.


Global Immuno-Oncology Assay Market Research Report: Forecast (2023-2028)

Global Immuno-Oncology Assay Market Driver:

Increasing Cancer Cases Globally to Drive Immuno-Oncology Assay Market– The substantial growth in the Global Immuno-Oncology Assay Market has been attributed to the increasing prevalence of cancer globally. The global incidence of cancer has risen significantly, with notable increases reported in countries such as the US and India, as documented by leading healthcare organizations like the World Health Organization, the International Agency for Research on Cancer, and the Global Cancer Observatory. For instance,

  • In 2018, the Global Cancer Observatory recorded approximately 18.1 million cancer cases worldwide, a number that escalated to approximately 19.2 million by 2020.

This surge in cancer cases has underscored the imperative for effective management. Consequently, countries, particularly the United States and India, have implemented measures to combat cancer, leading to heightened awareness among patients. This heightened awareness has driven the need for immune-oncology assays globally, catering to the need for early-stage detection and diagnosis.

Furthermore, global cancer research and healthcare organizations predict a continued increase in cancer cases in the years ahead. This prediction is based on factors such as the proliferation of carcinogenic pollutants in the environment and the growing prevalence of genetic mutations as significant contributors to cancer development. As a result, the demand for better immune-oncology diagnostic services would amplify in the coming years as well.

Global Immuno-Oncology Assay Market Opportunity:

Advancement in Immune Profiling Technologies to Drive Immuno-Oncology Assay Market– The field of Immuno-Oncology Assay is undergoing a transformation, driven by remarkable advancements in immune profiling technologies. The advancements in cutting-edge tools, such as high-dimensional flow cytometry, single-cell RNA sequencing, and multiplex immunohistochemistry, among others, are projected to amplify the market growth by enabling researchers and clinicians to delve deep into the complex immune responses taking place within tumor microenvironments. This precision in understanding the immune system's role in cancer would also enhance the identification of specific immune biomarkers and signatures linked to various cancer types and stages. As a result, the usage of immunoassays would amplify across the field of personalized cancer treatments, which are tailored to individual patients based on their immune profiles.

In addition, in recent years, companies like Meridian Bioscience, Inc., Roche, etc., have been introducing new biomarker assays, to improve the diagnosis of patients with various cancer types. For instance,

  • In 2023, Meridian Bioscience's Life Science division introduced two cutting-edge immunoassay interference blockers, K-Block™ and Mouse-Free IgG. These animal-free blockers are launched to advance sustainable raw materials for diagnostic assay makers.

Consequently, the launch of better biomarkers would improve the truly positive results of the immune-oncology-assays, and would further support the growth of the market in the coming years as well.

Global Immuno-Oncology Assay Market Challenge:

Shortage of Skilled Professionals Hampering the Market Growth– The market players in the Global Immuno-Oncology Assay market have been facing substantial challenges. One of those challenges is a critical shortage of skilled professionals, such as lab technicians and technologists, who possess the advanced laboratory expertise required to advance the field. This scarcity of qualified personnel represents a significant obstacle to the market's growth trajectory. For instance,

  • In 2022, according to the American Society for Clinical Pathology, the United States and Canada faced a significant lack of medical laboratory workers. There were only about one medical laboratory scientist for every 1,000 people, with a shortage of 20,000 to 25,000 professionals.

This dearth of skilled individuals with the necessary proficiency and experience not only impedes the efficiency of assays but also hampers the data interpretation step required for the assays. Also, as skilled professionals are required across research laboratories as well to carry out research and development processes, this is projected to hamper the development of high-end immunoassay services in the coming years.

Global Immuno-Oncology Assay Market Trend:

Increasing Adoption of Liquid Biopsy Techniques for Early Cancer Detection and Monitoring– The increasing adoption of liquid biopsy techniques for early cancer detection and monitoring in recent years represents a transformative shift in oncology. The growing adoption of liquid biopsies has gained traction through their potential to revolutionize cancer management by facilitating earlier interventions, more personalized treatment plans, and reduced patient discomfort.

Additionally, immunoassays have been largely preferred by clinical laboratories to detect cancer biomarkers using samples that are typically tagged with fluorescent, chemiluminescent, or oligo-coupled tags. It has been majorly attributed to the accuracy provided by the immunoassay techniques, which has improved its adoption along with liquid biopsy testing methods. Hence, the increasing adoption of liquid biopsy techniques has significantly supported the growth of immuno-oncology assay services demand in recent years.

In addition, there have been significant funding and strategic investments in liquid biopsy platforms, which reflect the growing interest in extracellular vesicle-based liquid biopsies. For instance,

  • In 2023, Mercy BioAnalytics, Inc. successfully raised USD 41 million in a Series A financing round led by Novalis LifeSciences and other notable participants from venture capital firms. The investment is focused on the advancement of the Mercy Halo™ Liquid Biopsy platform, which would allow the detection of multiple cancer-related biomarkers.

Thus, the increasing adoption of liquid biopsy techniques is a transformative trend set to drive substantial market growth in the coming years by offering more accessible, personalized, and effective cancer assay and treatment.

Global Immuno-Oncology Assay Market (2023-28): Segmentation Analysis

The Global Immuno-Oncology Assay Market study of MarkNtel Advisors evaluates & highlights the major trends & influencing factors in each segment. It includes predictions for the period 2023–2028 at the global level. Based on the analysis, the market has been further classified as:

Based on Product & Services:

  • Reagents and Antibodies
  • Testing Kits
  • Instruments
  • Consumables & Accessories
  • Software

Among them, reagents and antibodies are pivotal components that play a significant role in cancer diagnosis and monitoring, owing to which, they have been dominating the Global Immuno-Oncology Assay Market over the historical years. Reagents and antibodies hold strategic importance within the market as they are essential components in diagnostic assays and Immuno-Oncology therapies, impacting product development, innovation, and market competitiveness. Further, the development of new antibodies and reagents to improve the accuracy and effectiveness of immunoassays would directly influence the market's growth and advancement in cancer Assay and treatment. For instance,

  • In 2021, Agilent Technologies Inc. received the US FDA approval for PD-L1 IHC 22C3 pharmDx assay, as a companion diagnostic tool for the identification of triple-negative breast cancer (TNBC) patients suitable for pembrolizumab (Keytruda) treatment, thus enhancing the options for tailored therapy.

Consequently, these products empower healthcare professionals to detect and monitor interactions within the immune systems of cancer patients. Hence, the development of new diagnostic assays would require specific reagents and antibodies, which would further contribute to the growth of the segment in the coming years.

Based on Indication:

  • Lung Cancer
  • Breast Cancer
  • Colorectal Cancer
  • Prostate Cancer
  • Ovarian Cancer
  • Others (Bladder Cancer, Melanoma, etc.)

Among them all, the Prostate cancer segment commands the largest share in the market. This is primarily due to the increasing prevalence of prostate cancer worldwide. Prostate cancer ranks among the most common cancers in men, emphasizing the critical need for early diagnosis to determine appropriate treatment strategies. In recent years, there has been a notable preference among prostate cancer patients for immune-oncology assays, both for early diagnosis and personalized treatment. The advanced capabilities of these services to facilitate not only the early detection of prostate cancer but also enable personalized treatment plans, including optimizing the dosage of treatment drugs and therapies.

Furthermore, as the prevalence of prostate cancer continues to rise, researchers in countries such as the United States, Germany, South Korea, and others are intensifying their focus on this specific cancer type. Their efforts are aimed at developing advanced therapeutic methods for prostate cancer, which is expected to drive the demand for immune-oncology assays in the years to come.

Global Immuno-Oncology Assay Market (2023-28): Regional Projections

Geographically, the Global Immuno-Oncology Assay Market expands across:

  • North America
  • South America
  • Europe
  • Middle East & Africa
  • Asia-Pacific

North America's preeminence in the global Immuno-Oncology Assay Market is underpinned by a multifaceted landscape shaped by various factors. The region's extensive healthcare infrastructure and cutting-edge research and development facilities have propelled its leadership. North America, notably the United States, has been a focal point for pharmaceutical and biotechnology companies dedicated to advancing oncology Assay. Furthermore, the region's regulatory framework, led by the U.S. Food and Drug Administration (FDA), has streamlined the approval and commercialization of Immuno-Oncology diagnostic products, enhancing its competitive advantage.

Further, in recent years, several collaborations and partnerships among industry stakeholders, academic institutions, and healthcare providers have fostered innovation and accelerated the adoption of oncology assays. Simultaneously, the growing demand for personalized treatment plans, precision medicine, and advanced diagnostic tools has been instrumental in sustaining North America's dominance, which is projected to continue in the upcoming years as well.

Global Immuno-Oncology Assay Industry Recent Development:

  • 2023: Bio-Rad Laboratories, Inc. and Cytek Biosciences collaborated to utilize Bio-Rad's StarBright™ Dyes for creating reagent products that enhance high-parameter applications on Cytek's Aurora and Northern Lights™ flow cytometry systems, boosting their immuno-oncology assay and immunotherapy research capabilities.
  • 2022: Illumina's TruSight Oncology Comprehensive test has received its first companion diagnostic claim in Europe, enabling the matching of patients with rare NTRK gene fusions in any solid tumor to Bayer's Vitrakvi, marking the beginning of Illumina's broader partnerships with cancer drug manufacturers.

Gain a Competitive Edge with Our Global Immuno-Oncology Assay Market Report

  • Global Immuno-Oncology Assay Market Report by MarkNtel Advisors provides a detailed & thorough analysis of market size & share, growth rate, competitive landscape, and key players. This comprehensive analysis helps business organizations to gain a holistic understanding of the market dynamics & to make informed decisions.
  • This report also highlights current market trends & future projections, allowing business organizations to identify emerging opportunities & potential challenges. By understanding market forecasts, companies can align their strategies & stay ahead of the competition.
  • Global Immuno-Oncology Assay Market Report aids in assessing & mitigating risks associated with entering or operating level in the market. By understanding market dynamics, regulatory frameworks, and potential challenges, business organizations can develop strategies to minimize risks & optimize their operations.

Frequently Asked Questions

   A. The Immuno-Oncology Assay Market is expected to grow at a compound annual growth rate (CAGR) of 12.5% from 2023 to 2028.

   A. Increasing cancer cases globally is expected to drive the Immuno-Oncology Assay Market during 2023-28.

   A. The top players in the Immuno-Oncology Assay Market are Agilent Technologies Inc., Aviva Systems Biology Corporation, PerkinElmer Inc., Bio-Rad Laboratories, Inc., Illumina Inc., Qiagen N.V, Thermo Fisher Scientific, Inc., Sartorius AG, NanoString Technologies, Inc., BioGenex, Abbott Laboratories, Inc., Asuragen Inc., Meso Scale Assay, LLC, Merck Millipore, Enzo Biochem Inc., and Others.

   A. Reagents and Antibodies are the leading segment expected to hold a dominant share in the Immuno-Oncology Assay Market.

   A. North America would present growth prospects in the Immuno-Oncology Assay Market during 2023-28.

   A. Increasing adoption of liquid biopsy techniques for early cancer detection and monitoring is the key trend shaping the growth of the Immuno-Oncology Assay Market.

   A. Advancements in immune profiling technologies are the growth opportunities driving the Immuno-Oncology Assay Market.

Global Immuno-Oncology Assay Market Research Report (2023-2028) - Table of Contents

 

  1. Market Segmentation
  2. Introduction
    1. Product Definition
    2. Research Process
    3. Assumptions
  3. Executive Summary
  4. Global Immuno-Oncology Assay Market Patent Analysis
  5. Global Immuno-Oncology Assay Market Trends & Insights
  6. Global Immuno-Oncology Assay Market Dynamics
    1. Drivers
    2. Challenges
  7. Global Immuno-Oncology Assay Market Hotspot & Opportunities
  8. Global Immuno-Oncology Assay Market Policies, Regulations, Product Standards
  9. Global Immuno-Oncology Assay Market Outlook, 2018-2028F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Share & Analysis
      1. By Product & Services
        1. Reagents and Antibodies- Market Size & Forecast 2018-2028F, USD Million
        2. Testing Kits- Market Size & Forecast 2018-2028F, USD Million
        3. Instruments- Market Size & Forecast 2018-2028F, USD Million
        4. Consumables & Accessories- Market Size & Forecast 2018-2028F, USD Million
        5. Software- Market Size & Forecast 2018-2028F, USD Million
      2. By Assay Type
        1. Checkpoint Inhibitor Assays- Market Size & Forecast 2018-2028F, USD Million
        2. Cytokine Profiling Assays- Market Size & Forecast 2018-2028F, USD Million
        3. Protein Biomarker Assays- Market Size & Forecast 2018-2028F, USD Million
        4. Genomic Sequencing and Mutational Analysis- Market Size & Forecast 2018-2028F, USD Million
        5. Immune Profiling Assays- Market Size & Forecast 2018-2028F, USD Million
        6. Tumour Biomarker Assays-  Market Size & Forecast 2018-2028F, USD Million
        7. Others (Gene Expression Profiling Assays, Multiplex Assays, etc.)- Market Size & Forecast 2018-2028F, USD Million
      3. By Technology
        1. Polymerase Chain Reaction- Market Size & Forecast 2018-2028F, USD Million
        2. Immunoassay- Market Size & Forecast 2018-2028F, USD Million
        3. Next-generation Sequencing- Market Size & Forecast 2018-2028F, USD Million
        4. In-situ Hybridization- Market Size & Forecast 2018-2028F, USD Million
        5. Flow Cytometry- Market Size & Forecast 2018-2028F, USD Million
        6. Others (Mass Spectrometry, Immunohistochemistry (IHC), etc.) - Market Size & Forecast 2018-2028F, USD Million
      4. By Indication
        1. Lung Cancer- Market Size & Forecast 2018-2028F, USD Million
        2. Breast Cancer- Market Size & Forecast 2018-2028F, USD Million
        3. Colorectal Cancer- Market Size & Forecast 2018-2028F, USD Million
        4. Prostate Cancer- Market Size & Forecast 2018-2028F, USD Million
        5. Ovarian Cancer- Market Size & Forecast 2018-2028F, USD Million
        6. Others (Bladder Cancer, Melanoma, etc.)- Market Size & Forecast 2018-2028F, USD Million
      5. By Application
        1. Clinical Assay- Market Size & Forecast 2018-2028F, USD Million
        2. Research & Development- Market Size & Forecast 2018-2028F, USD Million
      6. By End User
        1. Hospitals- Market Size & Forecast 2018-2028F, USD Million
        2. Cancer Research Centers- Market Size & Forecast 2018-2028F, USD Million
        3. Specialty Cancer Clinics- Market Size & Forecast 2018-2028F, USD Million
        4. Clinical Laboratories- Market Size & Forecast 2018-2028F, USD Million
        5. Others (Contract Research Organizations (CROs), Contract Development & Manufacturing Organizations (CDMOs), etc.) - Market Size & Forecast 2018-2028F, USD Million
      7. By Region
        1. North America
        2. South America
        3. Europe
        4. Middle East & Africa
        5. Asia-Pacific
      8. By Competition
        1. Market Share of Top Companies
        2. Competition Characteristics
  10. North America Immuno-Oncology Assay Market Outlook, 2018-2028F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Share & Analysis
      1. By Product & Services- Market Size & Forecast 2018-2028F, USD Million
      2. By Assay Type- Market Size & Forecast 2018-2028F, USD Million
      3. By Technology- Market Size & Forecast 2018-2028F, USD Million
      4. By Indication- Market Size & Forecast 2018-2028F, USD Million
      5. By Application- Market Size & Forecast 2018-2028F, USD Million
      6. By End User- Market Size & Forecast 2018-2028F, USD Million
      7. By Country
        1. The US
        2. Canada
        3. Mexico
    3. The US Immuno-Oncology Assay Market Outlook, 2018-2028F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Product & Services- Market Size & Forecast 2018-2028F, USD Million
        2. By Indication- Market Size & Forecast 2018-2028F, USD Million
        3. By Application- Market Size & Forecast 2018-2028F, USD Million
    4. Canada Immuno-Oncology Assay Market Outlook, 2018-2028F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Product & Services- Market Size & Forecast 2018-2028F, USD Million
        2. By Indication- Market Size & Forecast 2018-2028F, USD Million
        3. By Application- Market Size & Forecast 2018-2028F, USD Million
    5. Mexico Immuno-Oncology Assay Market Outlook, 2018-2028F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Product & Services- Market Size & Forecast 2018-2028F, USD Million
        2. By Indication- Market Size & Forecast 2018-2028F, USD Million
        3. By Application- Market Size & Forecast 2018-2028F, USD Million
  11. South America Immuno-Oncology Assay Market Outlook, 2018-2028F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Share & Analysis
      1. By Product & Services- Market Size & Forecast 2018-2028F, USD Million
      2. By Assay Type- Market Size & Forecast 2018-2028F, USD Million
      3. By Technology- Market Size & Forecast 2018-2028F, USD Million
      4. By Indication- Market Size & Forecast 2018-2028F, USD Million
      5. By Application- Market Size & Forecast 2018-2028F, USD Million
      6. By End User- Market Size & Forecast 2018-2028F, USD Million
      7. By Country
        1. Brazil
        2. Rest of South America
    3. Brazil Immuno-Oncology Assay Market Outlook, 2018-2028F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Product & Services- Market Size & Forecast 2018-2028F, USD Million
        2. By Indication- Market Size & Forecast 2018-2028F, USD Million
        3. By Application- Market Size & Forecast 2018-2028F, USD Million
  12. Europe Immuno-Oncology Assay Market Outlook, 2018-2028F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Share & Analysis
      1. By Product & Services- Market Size & Forecast 2018-2028F, USD Million
      2. By Assay Type- Market Size & Forecast 2018-2028F, USD Million
      3. By Technology- Market Size & Forecast 2018-2028F, USD Million
      4. By Indication- Market Size & Forecast 2018-2028F, USD Million
      5. By Application- Market Size & Forecast 2018-2028F, USD Million
      6. By End User- Market Size & Forecast 2018-2028F, USD Million
      7. By Country
        1. Germany
        2. The UK
        3. France
        4. Italy
        5. Spain
        6. Rest of Europe
    3. Germany Immuno-Oncology Assay Market Outlook, 2018-2028F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Product & Services- Market Size & Forecast 2018-2028F, USD Million
        2. By Indication- Market Size & Forecast 2018-2028F, USD Million
        3. By Application- Market Size & Forecast 2018-2028F, USD Million
    4. The UK Immuno-Oncology Assay Market Outlook, 2018-2028F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Product & Services- Market Size & Forecast 2018-2028F, USD Million
        2. By Indication- Market Size & Forecast 2018-2028F, USD Million
        3. By Application- Market Size & Forecast 2018-2028F, USD Million
    5. France Immuno-Oncology Assay Market Outlook, 2018-2028F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Product & Services- Market Size & Forecast 2018-2028F, USD Million
        2. By Indication- Market Size & Forecast 2018-2028F, USD Million
        3. By Application- Market Size & Forecast 2018-2028F, USD Million
    6. Italy Immuno-Oncology Assay Market Outlook, 2018-2028F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Product & Services- Market Size & Forecast 2018-2028F, USD Million
        2. By Indication- Market Size & Forecast 2018-2028F, USD Million
        3. By Application- Market Size & Forecast 2018-2028F, USD Million
    7. Spain Immuno-Oncology Assay Market Outlook, 2018-2028F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Product & Services- Market Size & Forecast 2018-2028F, USD Million
        2. By Indication- Market Size & Forecast 2018-2028F, USD Million
        3. By Application- Market Size & Forecast 2018-2028F, USD Million
  13. Middle East & Africa Immuno-Oncology Assay Market Outlook, 2018-2028F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Share & Analysis
      1. By Product & Services- Market Size & Forecast 2018-2028F, USD Million
      2. By Assay Type- Market Size & Forecast 2018-2028F, USD Million
      3. By Technology- Market Size & Forecast 2018-2028F, USD Million
      4. By Indication- Market Size & Forecast 2018-2028F, USD Million
      5. By Application- Market Size & Forecast 2018-2028F, USD Million
      6. By End User- Market Size & Forecast 2018-2028F, USD Million
      7. By Country
        1. GCC
        2. South Africa
        3. Rest of Middle East & Africa
    3. GCC Immuno-Oncology Assay Market Outlook, 2018-2028F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Product & Services- Market Size & Forecast 2018-2028F, USD Million
        2. By Indication- Market Size & Forecast 2018-2028F, USD Million
        3. By Application- Market Size & Forecast 2018-2028F, USD Million
    4. South Africa Immuno-Oncology Assay Market Outlook, 2018-2028F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Product & Services- Market Size & Forecast 2018-2028F, USD Million
        2. By Indication- Market Size & Forecast 2018-2028F, USD Million
        3. By Application- Market Size & Forecast 2018-2028F, USD Million
  14. Asia-Pacific Immuno-Oncology Assay Market Outlook, 2018-2028F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Share & Analysis
      1. By Product & Services- Market Size & Forecast 2018-2028F, USD Million
      2. By Assay Type- Market Size & Forecast 2018-2028F, USD Million
      3. By Technology- Market Size & Forecast 2018-2028F, USD Million
      4. By Indication- Market Size & Forecast 2018-2028F, USD Million
      5. By Application- Market Size & Forecast 2018-2028F, USD Million
      6. By End User- Market Size & Forecast 2018-2028F, USD Million
      7. By Country
        1. China
        2. India
        3. Japan
        4. South Korea
        5. Australia
        6. Rest of Asia-Pacific
    3. China Immuno-Oncology Assay Market Outlook, 2018-2028F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Product & Services- Market Size & Forecast 2018-2028F, USD Million
        2. By Indication- Market Size & Forecast 2018-2028F, USD Million
        3. By Application- Market Size & Forecast 2018-2028F, USD Million
    4. India Immuno-Oncology Assay Market Outlook, 2018-2028F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Product & Services- Market Size & Forecast 2018-2028F, USD Million
        2. By Indication- Market Size & Forecast 2018-2028F, USD Million
        3. By Application- Market Size & Forecast 2018-2028F, USD Million
    5. Japan Immuno-Oncology Assay Market Outlook, 2018-2028F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Product & Services- Market Size & Forecast 2018-2028F, USD Million
        2. By Indication- Market Size & Forecast 2018-2028F, USD Million
        3. By Application- Market Size & Forecast 2018-2028F, USD Million
    6. South Korea Immuno-Oncology Assay Market Outlook, 2018-2028F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Product & Services- Market Size & Forecast 2018-2028F, USD Million
        2. By Indication- Market Size & Forecast 2018-2028F, USD Million
        3. By Application- Market Size & Forecast 2018-2028F, USD Million
    7. Australia Immuno-Oncology Assay Market Outlook, 2018-2028F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Product & Services- Market Size & Forecast 2018-2028F, USD Million
        2. By Indication- Market Size & Forecast 2018-2028F, USD Million
        3. By Application- Market Size & Forecast 2018-2028F, USD Million
  15. Global Immuno-Oncology Assay Market Key Strategic Imperatives for Success & Growth
  16. Competition Outlook
    1. Company Profiles
      1. Agilent Technologies Inc.
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      2. Aviva Systems Biology Corporation
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      3. PerkinElmer Inc.
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      4. Bio-Rad Laboratories, Inc.
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      5. Illumina Inc.
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      6. Qiagen N.V.
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      7. Thermo Fisher Scientific, Inc.
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      8. Sartorius AG
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      9. NanoString Technologies, Inc.
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      10. BioGenex
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      11. Abbott Laboratories, Inc.
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      12. Asuragen Inc.
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      13. Meso Scale Assay, LLC
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      14. Merck Millipore
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      15. Enzo Biochem Inc.
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      16. Others
  17. Disclaimer


Immuno-Oncology Assay Market Segmentation Slide